Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cells.
CONCLUSION: Our findings show that PLK4 inhibitors were effective against Ewing's sarcoma cells in vitro and thus provide a rationale for their evaluation in vivo.
PMID: 32770382 [PubMed - indexed for MEDLINE]
Source: Clin Med Res - Category: Research Authors: Kerschner-Morales SL, Kühne M, Becker S, Beck JF, Sonnemann J Tags: J Cancer Res Clin Oncol Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Childhood Cancer | Ewing's Sarcoma | Research | Sarcomas